Showing results (201-210 of 239) with videos related to

Sort By:
Pageof 24
Cancer Letters|July 12, 2012
NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cellsQi-Da Hu, Wei Chen, Tian-Lian Yan, et al.
Journal of Experimental Botany|March 13, 2014
Identification and utilization of cleistogamy gene cl7(t) in rice (Oryza sativa L.)Da-Hu Ni, Juan Li, Yong-Bo Duan, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 9, 2013
Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label studyYang Shen, Xiao-Jun Huang, Jian-Xiang Wang, et al.
Oncotarget|April 19, 2017
Bone marrow-derived mesenchymal stem cells overexpressing MiR-21 efficiently repair myocardial damage in ratsYan-Ling Zeng, Hao Zheng, Qiu-Ru Chen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2019
[Clinical Features and Prognosis of 35 Children with Burkitt Lymphoma/Leukemia]Yong-Zhi Zheng, Shao-Hua LE, Hao Zheng, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 4, 2021
[Clinical Features and Prognosis of Acute Lymphoblastic Leukemia Children with P2RY8-CRLF2 Gene Rearrangement]Yong-Zhi Zheng, Shao-Hua LE, Hao Zheng, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 18, 2019
[Clinical Features and Prognostic Factors of 18 Children with Anaplastic Large Cell Lymphoma]Cai Chen, Yong-Zhi Zheng, Xue-Ling Hua, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 8, 2021
[Clinical Effect and Safety of CCLG-ALL 2008 (high risk group) Protocol in the Treatment of Childhood Mixed Phenotype Acute Leukemia]Yong-Zhi Zheng, Shao-Hua LE, Hao Zheng, et al.
The Lancet. Oncology|June 10, 2018
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trialHong-Hu Zhu, De-Pei Wu, Xin Du, et al.
Genome Medicine|May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.
Pageof 24